{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:55:40Z","timestamp":1791197740789,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06831-1","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:53:15Z","timestamp":1791193995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Partial vs. whole-gland salvage hifu after radiotherapy failure: oncological and functional outcomes"],"prefix":"10.1007","volume":"44","author":[{"given":"Cyriel","family":"Maillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1331-3212","authenticated-orcid":false,"given":"Samy","family":"Mebroukine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Haaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Pasticier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bladou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"issue":"4","key":"6831_CR1","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","volume":"80","author":"V Beckendorf","year":"2011","unstructured":"Beckendorf V, Guerif S, Le Pris\u00e9 E, Cosset JM, Bougnoux A, Chauvet B et al (2011) 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial. Int J Radiat Oncol Biol Phys 15 juill 80(4):1056\u20131063 .049 PubMed PMID: 21147514","journal-title":"Int J Radiat Oncol Biol Phys 15 juill"},{"key":"6831_CR2","unstructured":"EAU Guidelines on Prostate Cancer - Uroweb [Internet]. [cit\u00e9 19 juin 2026]. Disponible sur: https:\/\/uroweb.org\/guidelines\/prostate-cancer"},{"issue":"3","key":"6831_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","volume":"80","author":"LF Valle","year":"2021","unstructured":"Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ et al (2021) A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol sept 80(3):280\u2013292 PubMed PMID: 33309278; PubMed Central PMCID: PMC10262981","journal-title":"Eur Urol sept"},{"issue":"5","key":"6831_CR4","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/j.juro.2006.07.075","volume":"176","author":"KM Sanderson","year":"2006","unstructured":"Sanderson KM, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G et al (2006) Salvage Radical Prostatectomy: Quality of Life Outcomes and Long-Term Oncological Control of Radiorecurrent Prostate Cancer. J Urol nov 176(5):2025\u20132032. https:\/\/doi.org\/10.1016\/j.juro.2006.07.075","journal-title":"J Urol nov"},{"issue":"5","key":"6831_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.urolonc.2013.12.014","volume":"32","author":"H Tran","year":"2014","unstructured":"Tran H, Kwok J, Pickles T, Tyldesley S, Black PC (2014) Underutilization of local salvage therapy after radiation therapy for prostate cancer11Funding: UBC Summer Student Research Program. Urologic Oncology: Seminars Original Investigations juill 32(5):701\u2013706. https:\/\/doi.org\/10.1016\/j.urolonc.2013.12.014","journal-title":"Urologic Oncology: Seminars Original Investigations juill"},{"issue":"2","key":"6831_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/cncr.23161","volume":"112","author":"PK Agarwal","year":"2008","unstructured":"Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR, Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE) (2008) Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 15 janv 112(2):307\u2013314. https:\/\/doi.org\/10.1002\/cncr.23161 PubMed PMID: 18050294","journal-title":"Cancer 15 janv"},{"issue":"11","key":"6831_CR7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/pros.24551","volume":"83","author":"RH Henderson","year":"2023","unstructured":"Henderson RH, Bryant C, Nichols RC, Mendenhall WM, Mendenhall NP (2023) Local salvage of radiorecurrent prostate cancer. Prostate 1 ao\u00fbt 83(11):1001\u20131010. https:\/\/doi.org\/10.1002\/pros.24551","journal-title":"Prostate 1 ao\u00fbt"},{"key":"6831_CR8","doi-asserted-by":"publisher","unstructured":"Roach M, Hanks G, Thames H, Schellhammer P, Shipley WU, Sokol GH et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. International Journal of Radiation Oncology Biology Physics. juill. ;65(4):965\u201374. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.04.029","DOI":"10.1016\/j.ijrobp.2006.04.029"},{"issue":"2","key":"6831_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey. Annals Surg ao\u00fbt 240(2):205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Annals Surg ao\u00fbt"},{"issue":"5","key":"6831_CR10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.eururo.2012.01","volume":"61","author":"DC Chade","year":"2012","unstructured":"Chade DC, Eastham J, Graefen M, Hu JC, Karnes RJ, Klotz L et al (2012) Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol mai 61(5):961\u2013971. https:\/\/doi.org\/10.1016\/j.eururo.2012.01.022 PubMed PMID: 22280856","journal-title":"Eur Urol mai"},{"issue":"11","key":"6831_CR11","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1080\/14737140.2020.1822742","volume":"20","author":"F Cuccia","year":"2020","unstructured":"Cuccia F, Mazzola R, Nicosia L, Giaj-Levra N, Figlia V, Ricchetti F et al (2020) Prostate re-irradiation: current concerns and future perspectives. Expert Rev Anticancer Therapy 1 nov 20(11):947\u2013956. https:\/\/doi.org\/10.1080\/14737140.2020.1822742","journal-title":"Expert Rev Anticancer Therapy 1 nov"},{"issue":"4","key":"6831_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.euo.2023.01.009","volume":"6","author":"D Pasquier","year":"2023","unstructured":"Pasquier D, Lacornerie T, Supiot S, Pommier P, Quivrin M, Simon JM et al (2023) The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study. Eur Urol Oncol 1 ao\u00fbt 6(4):399\u2013405. https:\/\/doi.org\/10.1016\/j.euo.2023.01.009 PubMed PMID: 36754722","journal-title":"Eur Urol Oncol 1 ao\u00fbt"},{"issue":"7","key":"6831_CR13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s00066-020-01628-6","volume":"196","author":"F Cuccia","year":"2020","unstructured":"Cuccia F, Nicosia L, Mazzola R, Figlia V, Giaj-Levra N, Ricchetti F et al (2020) Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer. Strahlenther Onkol juill 196(7):628\u2013636. https:\/\/doi.org\/10.1007\/s00066-020-01628-6","journal-title":"Strahlenther Onkol juill"},{"issue":"7","key":"6831_CR14","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.3390\/curroncol31070270","volume":"31","author":"S Sobhani","year":"2024","unstructured":"Sobhani S, Dadabhoy A, Ghoreifi A, Lebastchi AH (2024) Salvage High-Intensity Focused Ultrasound for Prostate Cancer after Radiation Failure: A Narrative Review. Curr Oncol 26 juin 31(7):3669\u20133681. https:\/\/doi.org\/10.3390\/curroncol31070270 PubMed PMID: 39057142; PubMed Central PMCID: PMC11276396","journal-title":"Curr Oncol 26 juin"},{"issue":"3","key":"6831_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/pcan.2016.23","volume":"19","author":"TT Shah","year":"2016","unstructured":"Shah TT, Peters M, Kanthabalan A, McCartan N, Fatola Y, van der Voort J et al (2016) PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure. Prostate Cancer Prostatic Dis sept 19(3):311\u2013316. https:\/\/doi.org\/10.1038\/pcan.2016.23 PubMed PMID: 27431499; PubMed Central PMCID: PMC4983180","journal-title":"Prostate Cancer Prostatic Dis sept"},{"issue":"2","key":"6831_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/bju.13831","volume":"120","author":"A Kanthabalan","year":"2017","unstructured":"Kanthabalan A, Peters M, Van Vulpen M, McCartan N, Hindley RG, Emara A et al (2017) Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer. BJU Int ao\u00fbt 120(2):246\u2013256. https:\/\/doi.org\/10.1111\/bju.13831 PubMed PMID: 28258616","journal-title":"BJU Int ao\u00fbt"},{"issue":"6","key":"6831_CR17","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/bju.13766","volume":"119","author":"S Crouzet","year":"2017","unstructured":"Crouzet S, Blana A, Murat FJ, Pasticier G, Brown SCW, Conti GN et al (2017) Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi\u2010institutional analysis of 418 patients. BJU Int juin 119(6):896\u2013904. https:\/\/doi.org\/10.1111\/bju.13766","journal-title":"BJU Int juin"},{"issue":"7","key":"6831_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.crad.2012.12.010","volume":"68","author":"O Rouvi\u00e8re","year":"2013","unstructured":"Rouvi\u00e8re O, Sbihi L, Gelet A, Chapelon JY (2013) Salvage high-intensity focused ultrasound ablation for prostate cancer local recurrence after external-beam radiation therapy: Prognostic value of prostate MRI. Clin Radiol juill 68(7):661\u2013667. https:\/\/doi.org\/10.1016\/j.crad.2012.12.010","journal-title":"Clin Radiol juill"},{"issue":"2","key":"6831_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1590\/s1677-5538.ibju.2017.0025","volume":"44","author":"S Dason","year":"2018","unstructured":"Dason S, Wong NC, Allard CB, Hoogenes J, Orovan W, Shayegan B (2018) High-Intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response. Int Braz J Urol 44(2):248\u2013257 2017.0025 PubMed PMID: 29211405; PubMed Central PMCID: PMC6050568","journal-title":"Int Braz J Urol"},{"issue":"2","key":"6831_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4111\/kju.2014.55.2.91","volume":"55","author":"W Song","year":"2014","unstructured":"Song W, Jung US, Suh YS, Jang HJ, Sung HH, Jeon HG et al (2014) High-Intensity Focused Ultrasound as Salvage Therapy for Patients With Recurrent Prostate Cancer After Radiotherapy. Korean J Urol f\u00e9vr 55(2):91\u201396 .91 PubMed PMID: 24578803; PubMed Central PMCID: PMC3935076","journal-title":"Korean J Urol f\u00e9vr"},{"key":"6831_CR21","doi-asserted-by":"publisher","unstructured":"Depaquit TL, Campagna J, Bastide C, Baboudjian M, Corral R, Uleri A et al (2024) Salvage High-intensity Focused Ultrasound (S-HIFU) for Recurrence after Primary Radiotherapy of Prostate Cancer. Fr J Urol 26 mars 102633. https:\/\/doi.org\/10.1016\/j.fjurol.2024.102633 PubMed PMID: 38547931","DOI":"10.1016\/j.fjurol.2024.102633"},{"issue":"5","key":"6831_CR22","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/bju.14838","volume":"124","author":"T Hostiou","year":"2019","unstructured":"Hostiou T, Gelet A, Chapelon JY, Rouvi\u00e8re O, M\u00e8ge-Lechevalier F, Lafon C et al (2019) Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after low-dose-rate brachytherapy: oncological and functional outcomes. BJU Int 124(5):746\u2013757. https:\/\/doi.org\/10.1111\/bju.14838","journal-title":"BJU Int"},{"issue":"8","key":"6831_CR23","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00345-019-02640-x","volume":"37","author":"B Devos","year":"2019","unstructured":"Devos B, Al Hajj Obeid W, Andrianne C, Diamand R, Peltier A, Everaerts W et al (2019) Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes. World J Urol ao\u00fbt 37(8):1507\u20131515. https:\/\/doi.org\/10.1007\/s00345-019-02640-x","journal-title":"World J Urol ao\u00fbt"},{"issue":"1","key":"6831_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.juro.2016.06.092","volume":"197","author":"KM Siddiqui","year":"2017","unstructured":"Siddiqui KM, Billia M, Arifin A, Li F, Violette P, Chin JL (2017) Pathological, Oncologic and Functional Outcomes of a Prospective Registry of Salvage High Intensity Focused Ultrasound Ablation for Radiorecurrent Prostate Cancer. J Urol janv 197(1):97\u2013102. https:\/\/doi.org\/10.1016\/j.juro.2016.06.092","journal-title":"J Urol janv"},{"issue":"4","key":"6831_CR25","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/bju.12545","volume":"114","author":"E Baco","year":"2014","unstructured":"Baco E, Gelet A, Crouzet S, Rud E, Rouvi\u00e8re O, Tonoli-Catez H et al (2014) Hemi salvage high\u2010intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two\u2010centre study. BJU Int oct 114(4):532\u2013540. https:\/\/doi.org\/10.1111\/bju.12545","journal-title":"BJU Int oct"},{"issue":"7","key":"6831_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1464-410X.2008.07775.x","volume":"102","author":"E Zacharakis","year":"2008","unstructured":"Zacharakis E, Ahmed HU, Ishaq A, Scott R, Illing R, Freeman A et al (2008) The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int oct 102(7):786\u2013792. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.07775.x","journal-title":"BJU Int oct"},{"issue":"17","key":"6831_CR27","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1002\/cncr.27394","volume":"118","author":"HU Ahmed","year":"2012","unstructured":"Ahmed HU, Cathcart P, McCartan N, Kirkham A, Allen C, Freeman A et al (2012) Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: A pilot study. Cancer sept 118(17):4148\u20134155. https:\/\/doi.org\/10.1002\/cncr.27394","journal-title":"Cancer sept"},{"issue":"2","key":"6831_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.prnil.2020.10.001","volume":"9","author":"JL Marenco Jimenez","year":"2021","unstructured":"Marenco Jimenez JL, Claps F, Ram\u00f3n-Borja JC, Mascar\u00f3s Martinez JM, Gutierrez AW, Lozano \u00c1GF et al (2021) Rebiopsy rate after transperineal or transrectal prostate biopsy. Prostate Int juin 9(2):78\u201381. https:\/\/doi.org\/10.1016\/j.prnil.2020.10.001 PubMed PMID: 34386449; PubMed Central PMCID: PMC8322821","journal-title":"Prostate Int juin"},{"issue":"11","key":"6831_CR29","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1001\/jamaoncol.2024.4000","volume":"10","author":"JC Hu","year":"2024","unstructured":"Hu JC, Assel M, Allaf ME, Vickers AJ, Ehdaie B, Cohen AJ et al (2024) Transperineal vs Transrectal Prostate Biopsy\u2014The PREVENT Randomized Clinical Trial. JAMA Oncol 1 nov 10(11):1590\u20131593. https:\/\/doi.org\/10.1001\/jamaoncol.2024.4000","journal-title":"JAMA Oncol 1 nov"},{"issue":"1","key":"6831_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.juro.2017.06.078","volume":"199","author":"TA Jones","year":"2018","unstructured":"Jones TA, Chin J, Mcleod D, Barkin J, Pantuck A, Marks LS (2018) High Intensity Focused Ultrasound for Radiorecurrent Prostate Cancer: A North American Clinical Trial. J Urol janv 199(1):133\u2013139. https:\/\/doi.org\/10.1016\/j.juro.2017.06.078","journal-title":"J Urol janv"},{"issue":"6","key":"6831_CR31","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.eururo.2014.09.028","volume":"67","author":"ZS Zumsteg","year":"2015","unstructured":"Zumsteg ZS, Spratt DE, Romesser PB, Pei X, Zhang Z, Polkinghorn W et al (2015) The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy. Eur Urol juin 67(6):1009\u20131016 .028 PubMed PMID: 25308970; PubMed Central PMCID: PMC5002994","journal-title":"Eur Urol juin"},{"issue":"6","key":"6831_CR32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.eururo.2019.11.023","volume":"77","author":"A Yokomizo","year":"2020","unstructured":"Yokomizo A, Wakabayashi M, Satoh T, Hashine K, Inoue T, Fujimoto K et al (2020) Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401)\u2020. Eur Urol juin 77(6):689\u2013698. https:\/\/doi.org\/10.1016\/j.eururo.2019.11.023","journal-title":"Eur Urol juin"},{"issue":"5","key":"6831_CR33","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.juro.2008.01.022","volume":"179","author":"SA Siddiqui","year":"2008","unstructured":"Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML (2008) Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. J Urol mai 179(5):1830\u20131837 discussion 1837. https:\/\/doi.org\/10.1016\/j.juro.2008.01.022","journal-title":"J Urol mai"},{"key":"6831_CR34","doi-asserted-by":"publisher","unstructured":"Shore ND, de Almeida Luz M, De Giorgi U, Gleave M, Gotto GT, Haas GP, LBA02-09 Embark: a phase 3 randomized study of enzalutamide or placebo plus leuprolide acetate and enzalutamide monotherapy in high-risk biochemically recurrent prostate cancer [Internet]. [cit\u00e9 20 juin 2026]. https:\/\/www.auajournals.org\/doi\/epdf\/https:\/\/doi.org\/10.1097\/JU.0000000000003361.09 doi:10.1097\/JU.0000000000003361.09","DOI":"10.1097\/JU.0000000000003361.09"},{"issue":"4","key":"6831_CR35","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3390\/cancers16040764","volume":"16","author":"A Sciarra","year":"2024","unstructured":"Sciarra A, Santarelli V, Salciccia S, Moriconi M, Basile G, Santodirocco L et al (2024) How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of Therapy. Cancers (Basel) 13 f\u00e9vr 16(4):764. https:\/\/doi.org\/10.3390\/cancers16040764 PubMed PMID: 38398155; PubMed Central PMCID: PMC10886975","journal-title":"Cancers (Basel) 13 f\u00e9vr"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06831-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06831-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06831-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:53:16Z","timestamp":1791193996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06831-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6831"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06831-1","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"16 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the local institutional ethics committee. Patients were informed and included under a non-opposition procedure in accordance with national data protection regulations.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"724"}}